Skip to content
Compare stocks

SpyGlass Pharma vs Vor Biopharma stock comparison

Score, categories, valuation, dividend, crash risk and price performance of SpyGlass Pharma and Vor Biopharma side by side. Figures from the overnight run, closing prices from 19 Nov 2026.

Key figures compared

SGPSpyGlass PharmaVORVor Biopharma
MEQIRI Score
Score4545
Fundamentals1020
Growth5050
Profitability1214
Valuationno datano data
Technical analysis6261
Momentum9382
Stability7249
Capital allocation4162
Price and valuation
Closing price$30.78$18.52
Market cap$1.03B$1B
P/ELossLoss
Forward P/ELoss expectedno data
Fair valueno datano data
Fair value versus priceno datano data
Growth and dividend
Revenue growth per yearno datano data
Dividend yield0.0%0.0%
Risk and performance
Crash riskno datano data
Price 1 yearno data+136.8%
Price 5 yearsno data−93.2%
IndustryBiotechnologyBiotechnology

Score and figures from the overnight run, closing prices from 19 Nov 2026. Amounts in US dollars, converted at the ECB rate. Price performance without dividends. The comparison shows figures and is not a recommendation to buy.

Price performance

  • SpyGlass Pharma
  • Vor Biopharma

All lines start at 100 on 11 February 2026, the first trading day of the youngest stock. Closing prices without dividends, each stock in its trading currency.

Questions and Answers

How do SpyGlass Pharma and Vor Biopharma compare on the MEQIRI Score?

The MEQIRI Score (0 to 100) is 45 for SpyGlass Pharma and 45 for Vor Biopharma. The category Stability differs most, with 72 for SpyGlass Pharma and 49 for Vor Biopharma. The score combines eight categories and is recalculated every night.

What is the P/E ratio of SpyGlass Pharma and Vor Biopharma?

SpyGlass Pharma: P/E Loss, forward P/E Loss expected. Vor Biopharma: P/E Loss, forward P/E no data. As of the close on 19 Nov 2026.

What is the dividend yield of SpyGlass Pharma and Vor Biopharma?

SpyGlass Pharma: 0.0%. Vor Biopharma: 0.0%. Based on payments over the last twelve months.

What is the crash risk of SpyGlass Pharma and Vor Biopharma?

SpyGlass Pharma: no data. Vor Biopharma: no data. Crash risk means a fall of 30% or more within a year, measured in the backtest against companies of similar size.

Why does the price chart start at 100?

All lines start at 100 on the same day. That shows performance regardless of a stock's price: 150 means 50% more than at the start, 80 means 20% less.

Does the comparison tell me which stock to buy?

No. MEQIRI shows figures and explains them, but gives no buy recommendation and no price target. The score helps you see strengths and weaknesses faster.

More comparisons

Compare stocks